Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
07/2003
07/01/2003US6586466 Carbohydrazide-protease inhibitors
06/2003
06/26/2003US20030119807 Inhibit Procollagen C-proteinase; antiscarring treatment for wounds.
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/19/2003WO2003051092A1 [5] helicene AND dibenzofluorene MATERIALS FOR USE IN ORGANIC LIGHT EMITTING DEVICES
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/17/2003US6579880 Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8
06/17/2003US6579871 Methods of using novel compounds as neuro-protective agents
06/12/2003WO2003048280A1 1,3,4-oxadiazole additives for lubricants
06/12/2003WO2003048139A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholipase of group ii
06/12/2003WO2003048121A1 Therapeutic benzamide derivatives
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003CA2469395A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholiphase of group ii
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317418A2 2-amino-2-alkyl-4 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317242A1 Use of 4-nitro-2,1,3-benzoxadiazol derivatives as dyes in colouring agents for keratin fibres
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/05/2003WO2003014094A3 Heterocyclic aryl sulphonamides
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105071 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders
06/04/2003CN1422261A 1,3,4-oxadiazole derivatives and process for producing the same
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044877A2 Light emitting device and compounds for use therein
05/30/2003WO2003043997A1 Peroxisome proliferator activated receptor alpha agonists
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/28/2003EP0882705B1 Bis(aminocarbonylnaphthol) derivative
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569896 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
05/22/2003WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003CA2467391A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566311 Ashless and non- phosphorus, non-sulfur-containing anti-wear, anti-fatigue, and extreme pressure additives
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040112A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/14/2003EP1310540A1 Polymer electroluminescent device
05/14/2003EP1309573A1 Urethane derivatives
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416424A Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
05/06/2003US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists
05/06/2003US6559100 2-benzoyl-cyclohexane-1,3-diones
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
04/2003
04/29/2003US6555691 Color developing agent, azo dye, silver halide photographic light-sensitive material, and image-forming method
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/24/2003WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
04/24/2003WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2003WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase
04/24/2003US20030078261 Prostaglandin agonists
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1303500A1 Heterocyclic fluoroalkenyl thioethers (ii)
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552201 Preparation of 3,3′-diamino-4,4′-azofurazan
04/22/2003US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels
04/17/2003WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/17/2003US20030073726 Heterocyclic inhibitors of glycine transporter 2
04/17/2003US20030073671 Side effect reduction; hormone replacement therapy
04/17/2003CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/16/2003CN1105717C Substituted sulphonylamino (thio) carbony/compounds
04/15/2003US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors
04/15/2003US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms
04/10/2003US20030069291 3-heterocyclylpropanohydroxamic acid PCP inhibitors
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003CN1408712A Novel mercapto oxdiazole derivative containing ether group and its salt compounds and their use
04/08/2003US6545030 1-heterocycle substituted diarylamines
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/08/2003US6544931 For controlling plant growth
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 72